BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31096519)

  • 1. Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies: A case report.
    Chung HY; Wickel J; Voss A; Ceanga M; Sell J; Witte OW; Geis C
    Medicine (Baltimore); 2019 May; 98(20):e15706. PubMed ID: 31096519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IgLON5 disease with distinctive brain MRI findings responding to immunotherapy: A case report.
    Pi Y; Zhang LL; Li JC
    Medicine (Baltimore); 2021 Jan; 100(4):e24384. PubMed ID: 33530233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide and immunotherapy can improve the outcome of severe anti-GABAB R encephalitis presenting with delta brush: A case report.
    Xiping W; Guomin X; Haifeng W; Qi S; Liping Z
    Medicine (Baltimore); 2020 Sep; 99(37):e22087. PubMed ID: 32925748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19.
    Li Y; Jia Y
    Front Immunol; 2023; 14():1195341. PubMed ID: 37383232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple intracranial lesions as the unusual imaging features of Hashimoto's encephalopathy: A case report.
    Kong FX; Lu QH; Guo ZK
    Medicine (Baltimore); 2018 May; 97(21):e10814. PubMed ID: 29794766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune encephalitis positive for both anti-γ-aminobutyric acid B receptor and anticollapsin response-mediator protein 5 antibodies: A case report.
    Xia J; Yin X; Zhu M; Cao J; Song X
    Medicine (Baltimore); 2018 Jan; 97(3):e9574. PubMed ID: 29504979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musical hallucinations: a rare and atypical presentation of anti-IgLON5 disease responsive to immunosuppressive therapy.
    Stoyanov A; McDougall A; Urriola N
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33602757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgLON5 Encephalopathy with Concomitant Herpes Virus Encephalitis.
    Wang Y; Li R; Sun X; Liao J; Li J; Xia H; Peng L; Qiu W; Shu Y
    Neuroimmunomodulation; 2022; 29(4):515-519. PubMed ID: 35354146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case report.
    Wang Y; Wu X; Lu B
    BMC Neurol; 2021 Mar; 21(1):120. PubMed ID: 33731000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognizing New-Onset Sleep Disorders in Autoimmune Encephalitis Often Prompt Earlier Diagnosis.
    Ralls F; Cutchen L; Grigg-Damberger MM
    J Clin Neurophysiol; 2022 Jul; 39(5):363-371. PubMed ID: 35239557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease.
    Gaig C; Compta Y
    Curr Opin Neurol; 2019 Jun; 32(3):493-499. PubMed ID: 30694925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan.
    Kong SS; Chen YJ; Su IC; Lin JJ; Chou IJ; Chou ML; Hung PC; Hsieh MY; Wang YS; Chou CC; Wang HS; Lin KL;
    Pediatr Neonatol; 2019 Aug; 60(4):417-422. PubMed ID: 30449706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review.
    McWilliam O; Gramkow MH; Blaabjerg M; Clemmensen FK; Hasselbalch SG; Frederiksen KS
    J Neurol; 2024 Apr; 271(4):1707-1716. PubMed ID: 38195895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Neuropsychological Findings in IgLON5 Antibody Disorder.
    El Shazly J; Juenemann M; Gerriets T; Tschernatsch M
    Front Neurol; 2021; 12():632497. PubMed ID: 33633675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5/CV2 and anti-GABAB receptor antibodies in small cell lung cancer: A case report.
    Li H; Zhang A; Hao Y; Guan H; Lv Z
    Medicine (Baltimore); 2018 May; 97(19):e0696. PubMed ID: 29742721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IgLON5 disease in a pediatric patient with Langerhans cell histiocytosis.
    Ye F; Fan C; Peng M; Liu S; Yu Y; Yang L
    Clin Chim Acta; 2021 Oct; 521():212-214. PubMed ID: 34270954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of anti-NMDAR and anti-IgLON5 antibodies in an autoimmune encephalitis patient: The first case report.
    Tian Y; Han L; Lenahan C; Wang T; Tian T; Liu R; Liu L; Huang J; Wang L; Hu X
    Heliyon; 2024 Mar; 10(5):e26659. PubMed ID: 38449620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features of anti-IgLON5 disease].
    Shimohata T; Kimura A
    Rinsho Shinkeigaku; 2021 Dec; 61(12):825-832. PubMed ID: 34789633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of Anti-SOX1 and Anti-GABA
    Qin W; Wang X; Yang J; Hu W
    Clin Interv Aging; 2020; 15():171-175. PubMed ID: 32103919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered ioflupane single-photon emission computed tomography in anti-IgLON5 disease: A new case mimicking probable progressive supranuclear palsy and review of the literature.
    González-Ávila C; Casado L; Muro García I; Villacieros-Álvarez J; Vivancos J; Quintas S
    Eur J Neurol; 2021 Apr; 28(4):1392-1395. PubMed ID: 33175431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.